FierceBiotech8d
Pfizer axes B7-H4 ADC, triggering $1B impairment charge as blockbuster vision evaporates
Pfizer has ended development of a B7-H4-directed antibody-drug conjugate (ADC), triggering a $1 billion impairment charge. | ...
What is Leerink Partnrs’ Forecast for ZNTL Q3 Earnings?
Leerink Partnrs issued their Q3 2025 earnings estimates for Zentalis Pharmaceuticals in a report issued on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will ...
Frontiers20d
Identification of key genes underlying radiosensitivity and radioresistance in endometrial cancer through integrated bioinformatics analysis
Additionally, we presented the expression patterns of these DEGs across the 32 samples using heatmaps (Figure 1B). In the heatmap ... tumor tissue samples post-radiotherapy for endometrial cancer due ...
Equities Analysts Offer Predictions for ZNTL Q1 Earnings
Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Zentalis Pharmaceuticals in a research note issued on Wednesday, February 5th. Leerink Partnrs ...
BMJ7d
Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome
Murine tissue IFA demonstrated colocalisation between commercial mouse TRIM46-IgG and patient-IgG on murine brain tissue (figure 1B ... initiation of ICI for cancer management. The first patient had ...
Short-course radiation matches standard therapy for endometrial cancer
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...
News Medical on MSN12h
Short-course, higher dose vaginal brachytherapy for endometrial cancer shown to be effective
In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...